1.中山大学医学院 广东 深圳518000
2.西藏大学医学院 西藏 拉萨 850000
肖若愚,第一作者, 研究方向: 高原慢性病; E-mail:1345379300@qq.com
纸质出版日期:2024-03-20,
收稿日期:2023-12-23,
录用日期:2024-03-14
扫 描 看 全 文
肖若愚,张玉飞,熊海.西藏西北地区藏族人群高同型半胱氨酸血症的患病现状与血尿酸血脂的关联性分析[J].中山大学学报(医学科学版),2024,45(02):324-330.
XIAO Ruoyu,ZHANG Yufei,XIONG Hai.Correlation Between the Prevalence of HHcy,Blood Lipids and Uric Acid in the Tibetan Population in Northwest Xizang[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(02):324-330.
肖若愚,张玉飞,熊海.西藏西北地区藏族人群高同型半胱氨酸血症的患病现状与血尿酸血脂的关联性分析[J].中山大学学报(医学科学版),2024,45(02):324-330. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240319.001.
XIAO Ruoyu,ZHANG Yufei,XIONG Hai.Correlation Between the Prevalence of HHcy,Blood Lipids and Uric Acid in the Tibetan Population in Northwest Xizang[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(02):324-330. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240319.001.
目的
2
为了了解西藏西北地区藏族人群高同型半胱氨酸血症(HHcy)患病现状及其与血脂、血尿酸等的关联,探讨西藏西北地区高同型半胱氨酸血症等慢性病的防治策略。
方法
2
本次调查采用多阶段分层整群随机抽样的方法,对西藏西北地区(阿里地区、那曲市)居住6个月以上、18岁及以上的3 432名藏族居民进行了问卷调查、体格检查以及生化检测等。
结果
2
西藏西北地区藏族居民HHcy患病率为75.7%,远高于我国平均人群的患病率(37.2%)。血尿酸、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇是HHcy的危险因素。
结论
2
西藏西北地区藏族人群的HHcy患病率高。当地政府应敦促人们建立健康的生活方式,通过改善饮食和生活方式,加强对HHcy的早期干预,降低心脑血管等相关疾病的发生风险。
Objectives
2
To understand the prevalence of hyperhomocysteinemia (HHcy) in the Tibetan population in Northwest Xizang, and its association with lipids and blood uric acid, and to explore the prevention and treatment strategies for chronic diseases such as HHcy in Northwest Xizang.
Methods
2
In this survey, questionnaires, physical examinations, and biochemical tests were conducted on 3432 Tibetan residents aged 18 years and older who had resided in Northwest Xizang (Ngari Prefecture, Nagqu City) for more than 6 months using a multistage stratified whole cluster random sampling method.
Results
2
The prevalence of HHcy among Tibetan residents in Northwest Xizang was 75.7%, much higher than that of the average population in China (37.2%). Blood uric acid、high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were risk factors for HHcy.
Conclusion
2
The prevalence of HHcy is higher in the Tibetan population in northwest Xizang. Therefore, the local governments should urge people to establish a healthy lifestyle and enhance early intervention for HHcy by improving diet and lifestyle, thereby reducing the risk of cardiovascular, cerebrovascular and other related diseases.
西藏西北地区高同型半胱氨酸血症血脂血尿酸关联性
Northwest Xizanghyperhomocysteinemiablood lipidsblood uric acidassociation
Conri C, Constans J, Parrot F, et al. Homocysteinemia: role in vascular disease[J]. Presse Med, 2000, 29(13):737-741.
吴宇航,颜玮,徐艳,等.高血压和高同型半胱氨酸与脑卒中相关性分析[J]. 现代预防医学,2023,50(13):2319-2325.
Wu YH,Yan W,Xu Y,et al. Analysis of the relationship of hypertension and hyperhomocysteine with stroke[J]. Modern Prevent Med,2023,50(13):2319-2325.
徐琳,于鲁璐,王岚,等. 血浆同型半胱氨酸水平与男性酒依赖患者复饮相关性研究[J]. 中国神经精神疾病杂志,2020,46(12):725-729.
Xu L,Yu LL,Wang L,et al.The study on the correlation between plasma homocysteine level and relapse in made alcohol dependent patients[J]. Chin J Nerv Ment Dis,2020,46(12):725-729.
Tseng FC, Huang TC. Using data mining technology to explore homocysteine at low levels[J]. Medicine (Baltimore), 2021, 100(33):e26893.
Selhub J, Rosenberg IH. Excessive folic acid intake and relation to adverse health outcome[J]. Biochimie, 2016, 126:71-78.
Herrmann W, Lorenzl S, Obeid R. Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--Current evidence and preliminary recommendations[J]. Fortschr Neurol Psychiatr, 2007, 75(9):515-527.
Li Z, Guo X, Chen S, et al. Hyperhomocysteinemia independently associated with the risk of hypertension: a cross-sectional study from rural China[J]. J Hum Hypertens, 2016,30(8):508-512.
Shen L, Zhang X, Dawawuzhu, et al. Pain clinic in Tibet, China: a single-center retrospective study[J]. Pain Res Manag, 2019,2019:9161906.
王友发, 孙明晓, 薛宏, 等. 《中国肥胖预防和控制蓝皮书》解读及中国肥胖预防控制措施建议[J]. 中华预防医学杂志, 2019(9):875-884.
Wang YF, Sun MX, Xue H, et al. Interpretation of the Blue Book on Obesity Prevention and Control in China and suggestions for obesity prevention and control measures in China [J] Chin J Prev Med,2019(9):875-884.
中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1):24-56.
Chinese Guidelines for the Prevention and Treatment of Hypertension (Revised 2018)[J]. Chin J Cardiovasc Med, 2019, 24 (1): 24-56.
中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志, 2020(1):1-2.
Guidelines for the Diagnosis and Treatment of Hyperuricemia and Gout in China (2019)[J] Chin J Endocrinol Metab, 2020(1): 1-2.
Zhao SP. Amendment of the low-density lipoprotein cholesterol target in the 'Chinese Guidelines for the Prevention and Treatment of Adult Dyslipidemia': opinion[J]. Chronic Dis Transl Med, 2016,2(1):7-9.
Stehouwer C. Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences[J]. Diabetes, 2018, 67(9):1729-1741.
Andrew ML, Philip NA, Justin SL, et al. Ward, milledge and West’s high altitude medicine and physiology[M]. CRC Press, 2021.
Guo Z, Li X, Wang T, et al. Elevated serum homocysteine levels are associated with the development of chronic venous ulcers[J]. Vasc Med, 2022, 27(4):358-364.
张玉飞, 格桑平措, 邱海兵, 等. 西藏阿里地区西部区域藏族人群慢性病及影响因素的相关性研究[J]. 现代预防医学, 2022, 49(23):4246-4252.
Zhang YF, Gesang PC, Xiong H, et al. A correlation study on chronic diseases and influencing factors among the Tibetan population in the western region of Ali region, Tibet[J]. Modern Prev Med, 2022, 49(23):4246-4252.
Zeng Y, Li FF, Yuan SQ, et al. Prevalence of hyperhomocysteinemia in China: an updated meta-analysis[J]. Biology (Basel), 2021,10(10):959.
Qin YY, Wang P, Qin JQ, et al. Prevalence of hyperhomocysteinemia during routine physical examination in Guangxi Province, China and related risk factors[J]. J Clin Lab Anal, 2018,32(1).e22178.
Wang Y, Li X, Qin X, et al. Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45-75 years[J]. Br J Nutr, 2013, 109(7):1284-1293.
李启雯, 格桑平措, 张玉飞, 等. 西藏阿里西部区域高血压与同型半胱氨酸和脑卒中风险基因的关系[J]. 现代预防医学, 2022, 49(11):2065-2068.
Li QW, Gesang PC, Zhang YF, et al. Association of hypertension with homocysteine and stroke risk genes in the western region of Ali, Tibet[J]. Modern Prevent Med, 2022, 49(11):2065-2068.
郭紫. 血清同型半胱氨酸的影响因素及其对血尿酸影响的分析[D]. 大连医科大学, 2021.
Guo Z. Analysis of the influencing factors of serum homocysteine and its impact on blood uric acid [D]. Dalian Medical University, 2021.
李杨, 沈洁, 申亚丽, 等. 高同型半胱氨酸血症在冠心病患者中的意义[J]. 中国医科大学学报, 2014, 43(10):885-888.
Li Y, Shen J, Shen YL, et al. The significance of hyperhomocysteinemia in patients with coronary heart disease [J] Journal of China Medical University, 2014, 43(10):885-888.
Cohen E, Levi A, Vecht-Lifshitz SE, et al. Assessment of a possible link between hyperhomocysteinemia and hyperuricemia[J]. J Investig Med, 2015,63(3):534-538.
Yadav AS, Bhagwat VR, Rathod IM. Relationship of plasma homocysteine with lipid profile parameters in ischemic heart disease[J]. Indian J Clin Biochem, 2006, 21(1):106-110.
方兴, 江颖, 欧俐羽, 等. 脑梗死患者同型半胱氨酸与血脂相关性及其诊断价值[J]. 实用医学杂志, 2017, 33(22):3819-3821.
Fang X, Jiang Y, Ou LY, et al. The correlation between homocysteine and blood lipids in patients with cerebral infarction and its diagnostic value [J] J Practical Med, 2017, 33(22):3819-3821.
Mahalle N, Kulkarni MV, Garg MK, et al. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease[J]. J Cardiol, 2013, 61(4):289-294.
0
浏览量
6
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构